{"id":603,"date":"2024-09-10T12:11:45","date_gmt":"2024-09-10T12:11:45","guid":{"rendered":"https:\/\/www.hamptonhealthpharmacy.co.uk\/online\/?p=603"},"modified":"2024-09-10T12:11:45","modified_gmt":"2024-09-10T12:11:45","slug":"glp-1-receptor-agonists-the-rising-stars","status":"publish","type":"post","link":"https:\/\/www.hamptonhealthpharmacy.co.uk\/online\/glp-1-receptor-agonists-the-rising-stars\/","title":{"rendered":"GLP-1 Receptor Agonists: The Rising Stars in Diabetes and Weight Management"},"content":{"rendered":"

As pharmacists, we’re witnessing a significant shift in the treatment landscape for Type 2 diabetes<\/a> and obesity. GLP-1 receptor agonists have emerged as game-changers, with projections suggesting they could become the pharmaceutical industry’s best-selling drugs by 2024. Let’s dive into what this means for our practice and our patients.<\/p>\n

What Are GLP-1 Receptor Agonists?<\/h2>\n

GLP-1 receptor agonists are a class of medications that mimic the action of the naturally occurring hormone GLP-1 (glucagon-like peptide-1). They work by:<\/p>\n

    \n
  1. Stimulating insulin release<\/li>\n
  2. Inhibiting glucagon secretion<\/li>\n
  3. Slowing gastric emptying<\/li>\n
  4. Increasing satiety and reducing food intake<\/li>\n<\/ol>\n

    These combined effects help manage blood sugar levels and promote weight loss, making them valuable tools in our arsenal against diabetes and obesity.<\/p>\n

    The Evolution of GLP-1 Agonists<\/h2>\n

    The journey of GLP-1 agonists began in 2005 with exenatide, which required twice-daily injections. Over the years, we’ve seen remarkable improvements:<\/p>\n